The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.
Sign in to access this content
Sign InIn a move reflecting the drive by major consumer goods companies to capture a larger share of the expanding wellness market, Procter & Gamble has announced its intention to acquire the Thorne supplements brand. According to the company's CEO, this strategic acquisition is designed to expand P&G's health business. The deal aims to accelerate growth within the personal healthcare segment by capitalizing on the premium health and wellness market.
The acquisition follows recent earnings reports as P&G seeks to bolster its margins through high-quality healthcare products. Per market data, PG stock closed at $144.98 (close August 03, 2026), having traded between a day high of $147.15 and a day low of $144.26 during that session.
Investors are now watching how this acquisition will drive long-term growth while PG shares maintain their current levels. Looking at the broader economic context, the markets recently processed the Fed's decision to hold interest rates at 3.75% on July 29, 2026, providing a stable financing environment for M&A activity in the consumer sector.
Update: Reports indicate the acquisition is valued at approximately $3.8 billion in cash, payable to the global investment firm L Catterton. This definitive agreement provides clarity on P&G's capital commitment toward its expansion into the supplements sector.
Update: Subsequent reports have valued Procter & Gamble's acquisition of Thorne at $3.8 billion. This valuation represents a significant investment, signaling the company's confidence in the long-term returns of the premium supplement sector.
Update: Thorne announced on August 4, 2026, that it has entered into a definitive agreement to be acquired by The Procter & Gamble Company. Thorne, headquartered in Summerville, South Carolina, marks this signing as a critical step toward the formal completion of the deal.
Update: P&G CEO Shailesh Jejurikar confirmed in a CNBC interview that the acquisition of Thorne is valued at $3.8 billion. This financial disclosure highlights the scale of the investment the group is making to solidify its position in the supplements market.